0001209191-20-002600.txt : 20200108
0001209191-20-002600.hdr.sgml : 20200108
20200108180641
ACCESSION NUMBER: 0001209191-20-002600
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200106
FILED AS OF DATE: 20200108
DATE AS OF CHANGE: 20200108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIM AUSTIN D.
CENTRAL INDEX KEY: 0001746240
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 20516667
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-06
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001746240
KIM AUSTIN D.
C/O ACADIA PHARMACEUTICALS INC.
3611 VALLEY CENTRE DRIVE, STE. 300
SAN DIEGO
CA
92130
0
1
0
0
EVP & General Counsel
Stock Options (Right to Buy)
42.81
2020-01-06
4
A
0
23709
0.00
A
2030-01-06
Common Stock
23709
23709
D
Restricted Stock Units
2020-01-06
4
A
0
6533
0.00
A
Common Stock
6533
6533
D
25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The restricted stock units vest in four equal annual installments beginning January 6, 2021.
/s/ Austin D. Kim
2020-01-08